Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MDxHealth (MDXH) Net Income towards Common Stockholders (2025 - 2026)

MDxHealth has reported Net Income towards Common Stockholders over the past 2 years, most recently at -$8.9 million for Q1 2026.

  • For Q1 2026, Net Income towards Common Stockholders rose 0.76% year-over-year to -$8.9 million; the TTM value through Mar 2026 reached -$17.8 million, down 99.24%, while the annual FY2025 figure was -$33.5 million, 11.95% up from the prior year.
  • Net Income towards Common Stockholders was -$8.9 million for Q1 2026 at MDxHealth, up from -$8.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$8.9 million in Q1 2026 and bottomed at -$8.9 million in Q1 2025.